Combination Chemotherapy in Treating Patients With Resected Colon Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

1,608

Participants

Timeline

Start Date

February 28, 1997

Primary Completion Date

May 31, 2006

Study Completion Date

April 30, 2009

Conditions

Colorectal Cancer

Interventions

DRUG

5-fluorouracil

DRUG

leucovorin calcium

DRUG

tegafur

DRUG

uracil

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

NSABP Foundation Inc

NETWORK

NCT00378716 - Combination Chemotherapy in Treating Patients With Resected Colon Cancer | Biotech Hunter | Biotech Hunter